5 min listen
How Long Should You Continue Bisphosphonate Treatment for Osteoporosis? - Frankly Speaking Ep 225
FromPri-Med Podcasts
How Long Should You Continue Bisphosphonate Treatment for Osteoporosis? - Frankly Speaking Ep 225
FromPri-Med Podcasts
ratings:
Length:
9 minutes
Released:
May 24, 2021
Format:
Podcast episode
Description
Credits: 0.25 AMA PRA Category 1 Credit™
CME/CE Information and Claim Credit: https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-225
Overview: Join us for this episode as we review the recently published (Dec. 2020) cohort study in JAMA on using bisphosphonates to prevent hip fractures. We will review the utility of bisphosphonates after 5 years and how to discuss their risks and benefits with patients.
Episode resource links:
JAMA.2020;3(12):e2025190.doi:10.1001/jamanetworkopen.2020.25190
JAMA. 2018;319(24):2521-2531. doi:10.1001/jama.2018.7498
https://www.sheffield.ac.uk/FRAX/tool.aspx?country=9
Guest: Robert A. Baldor MD, FAAFP
Music Credit: Richard Onorato
CME/CE Information and Claim Credit: https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-225
Overview: Join us for this episode as we review the recently published (Dec. 2020) cohort study in JAMA on using bisphosphonates to prevent hip fractures. We will review the utility of bisphosphonates after 5 years and how to discuss their risks and benefits with patients.
Episode resource links:
JAMA.2020;3(12):e2025190.doi:10.1001/jamanetworkopen.2020.25190
JAMA. 2018;319(24):2521-2531. doi:10.1001/jama.2018.7498
https://www.sheffield.ac.uk/FRAX/tool.aspx?country=9
Guest: Robert A. Baldor MD, FAAFP
Music Credit: Richard Onorato
Released:
May 24, 2021
Format:
Podcast episode
Titles in the series (100)
Updates On Screening from the USPSTF (FAQ): FAQ for Updates On Screening from the USPSTF (Not for CME credit) Guest: Ronald Adler, MD, FAAFP by Pri-Med Podcasts